This work is relevant since identifying targets that specifically modulate cancer cell radiosensitivity and can do so even in the absence of robust tumor CD8+ T cell infiltration could lead the way to improving treatment outcomes for the most difficult to treat tumors. This evidence concerns the gene CD8A and cancer.